Novo Nordisk A/S

Danemark


 
Quantité totale PI 2 329
Quantité totale incluant filiales 2 334 (+ 5 pour les filiales)
Rang # Quantité totale PI 533
Note d'activité PI 3,7/5.0    1 097
Rang # Activité PI 664
Symbole boursier
ISIN DK0060534915
Capitalisation 2.4T  (DKK)
Industrie Biotechnology
Secteur Healthcare
Classe Nice dominante Produits pharmaceutiques, vétéri...

Brevets

Marques

600 112
65 96
1 103 196
157
 
Dernier brevet 2024 - Drug delivery device for deliver...
Premier brevet 1975 - 4-phenylpiperidine compounds
Dernière marque 2024 - Wegovy Patix
Première marque 1976 - MIXTARD

Filiales

1 subsidiaries with IP (5 patents, 0 trademarks)

 S'inscrire grtuitement pour accéder à la liste des filiales

Industrie (Classification de Nice)

Derniers inventions, produits et services

2024 P/S Pharmaceutical preparations for the treatment of liver diseases..
2023 P/S Pharmaceutical preparations for the treatment of diabetes; pharmaceutical preparations for weight...
P/S Pharmaceutical preparations for the treatment of diabetes; pharmaceutical preparations for weigh...
P/S Pharmaceutical preparations for the treatment of diabetes; Pharmaceutical preparations for weight...
P/S Downloadable software applications for use with diabetes management Medical information services ...
P/S Downloadable materials, namely, educational videos, podcasts, multimedia files, audio, images, an...
Invention Solid compositions comprising a glp-1 agonist and a salt of n-(8-(2-hydroxybenzoyl)amino)caprylic...
P/S Pharmaceutical preparations for the treatment and prevention of hypoglycemia; medical preparation...
Invention Prodrugs and uses thereof. Prodrug compounds of GLP-1/GIP receptor co-agonists are provided wher...
Invention Semaglutide for use in medicine. The present invention is directed to use of the GLP-1 receptor ...
P/S Waste collection, waste storage, waste removal Waste treatment, waste recycling services
P/S Waste collection, waste storage, waste removal. Waste treatment, waste recycling services.
Invention A sirp-alpha binding chimeric protein. The present disclosure provides chimeric proteins comprisi...
Invention Pharmaceutical composition comprising mineralocorticoid receptor antagonist and use thereof. Pro...
P/S Downloadable software applications for use with diabetes management. Medical information services...
Invention Factor x binders enhancing fx activation. The application relates to unique FX binding molecules...
P/S Pharmaceutical preparations for the treatment of liver diseases.
Invention Novel anti-angptl3 antibodies suitable for high concentration compositions and subcutaneous admin...
Invention Ingestible device with rotational trigger release. A capsule device (100.2) suitable for ingestio...
Invention Ingestible device with rotational drive mechanism. A capsule device (100.1) suitable for ingestio...
P/S Enzymes for industrial purposes.
P/S Enzymes for industrial purposes
P/S Enzymes for industrial purposes.
Invention Compositions of glp-1 peptides and preparation thereof. The invention relates to pharmaceutical ...
Invention Glp-1 compositions and uses thereof. The present invention relates to pharmaceutical composition...
Invention Highly potent isvd compounds capable of substituting for fviii(a). The present invention provide...
Invention Highly potent isvd compounds capable of substituting for fviii(a). The present invention provides...
Invention Differentiation of stem cells to pancreatic endocrine cells. in vitroin vitro method for producin...
Invention Enhancing neuronal differentiation of ventral midbrain neural progenitor cells. The present inven...
P/S Educational services, namely, conducting educational programs, developing education manuals; prov...
Invention Compositions and methods for inhibiting transmembrane serine protease 6 (tmprss6) expression. Oli...
Invention Systems and methods for regimen adherence evaluation. A diabetes management system adapted to det...
P/S Pharmaceutical preparations.
Invention Glucose-sensitive albumin-binding derivatives. This invention relates to glucose-sensitive album...
Invention An applicator system and a blister package for the applicator system. The present invention relat...
P/S Downloadable podcasts and downloadable written articles and video recordings on the subject of he...
Invention Selective elimination of erosive cells. The current invention relates to the treatment of diseas...
P/S Pharmaceutical preparations for the treatment of neurodegenerative disorders and diseases
Invention Drug delivery device with adapted to prevent an unintended dose. A drug delivery device (300) com...
Invention Prodrugs of glp-1 polypeptide and uses thereof. The invention relates to DKP-based prodrugs from ...
Invention Anti-angptl3 antibodies suitable for high concentration compositions and subcutaneous administrat...
Invention Dose logging device with scale drum scanner. A drug delivery device comprising a housing with an ...
Invention Compositions and methods for inhibiting mitochondria amidoxime reducing component 1 (marc1) expre...
Invention Formulation method. Disclosed herein is a method of co-formulating an amylin receptor agonist and...
2022 Invention Mic-1 compounds and uses thereof. The invention relates to MIC-1 compounds. More specifically it...
Invention Co-agonists of the glp-1 and amylin receptors. The invention relates to a compound comprising a ...
Invention Propylene glycol-containing peptide formulations which are optimal for production and for use in ...
Invention Drug delivery device for delivering a predefined fixed dose. 1. A drug delivery device for deliv...
Invention Drug delivery device for delivering a predefined fixed dose. A drug delivery device (100, 300) f...
Invention Drug delivery device for delivering a predefined fixed dose. A drug delivery device (100, 300), ...
Invention A torsion spring driven fixed dose injection device. The invention relates to a medical injectio...
2021 Invention Fast data transmission feature for medical logging device. A drug delivery device comprising ele...
Invention Compounds and their use in treatment of tachykinin receptor mediated disorders. The present inve...
Invention Substance delivering capsule. 1. A capsule device (100) suitable for swallowing into a lumen of ...
Invention Dose logging sensor system with error detection feature. A drug delivery system comprising drug ...
Invention Glp-1, gip and glucagon receptor triple agonists. The invention relates to peptides and derivati...
Invention Anti-transthyretin antibodies and methods of use thereof. Provided herein are methods and compos...
Invention Capsule device. A capsule device (100) suitable for insertion or ingestion into a lumen, such as...
Invention Device for intestinal drug delivery. An ingestible jet injection device for introducing a fluid ...
Invention A swallowable capsule device. The swallowable capsule device (10) comprises a capsule housing (1...
Invention A swallowable capsule device. A capsule device (10) suitable for swallowing into a lumen of an i...
Invention Lumen insertable capsule. A capsule device (100) suitable for insertion into a lumen, such as a ...
Invention Method for screening in vitro population of stem cell derived beta like cells and novel markers t...
Invention Glp-1 and gip receptor co-agonists. Peptide co-agonists of the human GLP-1 and GIP receptors, lo...
Invention Use of pluripotent markers to detect contaminating residual undifferentiated pluripotent stem cel...